A Phase I Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Advanced Solid Malignancies
Phase of Trial: Phase I
Latest Information Update: 25 May 2015
At a glance
- Drugs Veliparib (Primary) ; Carboplatin; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 20 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jul 2012 Planned end date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.